Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Trial in Adult Subjects With Spinocerebellar Ataxia
      Description

      The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA).

      Conditions
      Spinocerebellar AtaxiasSpinocerebellar Ataxia Genotype Type 1Spinocerebellar Ataxia Genotype Type 2Spinocerebellar Ataxia Genotype Type 3Spinocerebellar Ataxia Genotype Type 6Spinocerebellar Ataxia Genotype Type 7Spinocerebellar Ataxia Genotype Type 8Spinocerebellar Ataxia Genotype Type 10
      Talk to us